SCHEMBL8220437

SCHEMBL8220437

O=c1cc(-c2ccsc2)c(-c2ccccc2)n[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.57
CYP2A6 P11509 2/20 0.48
CYP2B6 P20813 2/20 0.48
CYP2E1 P05181 1/20 0.48
ADORA2A P29274 2/20 0.45
PTGS1 P23219 2/20 0.45
ATM Q13315 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CDK8 P49336 1/20 0.45
MAOB P27338 1/20 0.43
PTPRC P08575 1/20 0.43
GLO1 Q04760 1/20 0.42
CYP1A2 P05177 1/20 0.42
CCNE2 O96020 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474844 0.84 HPGD (0.70) HPGDPTGS1ATMNPSR1CYP1A2
SCHEMBL1752766 0.74 HPGD (0.57) HPGDPTGS1ATMNPSR1CYP1A2
SCHEMBL11144936 0.73 HPGD (0.64) HPGDPTGS1ATMNPSR1CDK8
SCHEMBL1550943 0.73 HPGD (1.00) HPGDPTGS1ATMNPSR1CYP1A2
SCHEMBL8898020 0.73 HPGD (0.64) HPGDPTGS1ATMNPSR1CDK8
SCHEMBL10288495 0.73 HPGD (0.64) HPGDPTGS1ATMNPSR1CYP1A2
SCHEMBL701571 0.73 HPGD (0.64) HPGDADORA2APTGS1ATMNPSR1
SCHEMBL9251834 0.72 ATM (0.64) ADORA2AATMNPSR1KDM4EALDH1A1
SCHEMBL31014291 0.72 ATM (0.64) ADORA2AATMNPSR1KDM4EALDH1A1
SCHEMBL3946521 0.72 HPGD (0.54) HPGDPTGS1ATMNPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008019266-A2 ACYCLIC, PYRIDAZINONE-DERIVED HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-14 WO disclosed